Patient P-02576

Synthetic patientMETA-24 · Day 153 · 45–54 · F · baseline S17Steering view · 3D Open companion preview

Therapy response

Declining

Tolerance

Deteriorating

GI state

Deteriorating

Inflammatory state

Deteriorating

Nutritional resilience

Declining

Discontinuation risk

57%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S17
Day 29 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 29.

Primary contributors, last 14 days

GI instability+30
Inflammatory activity+22
Nutritional resilience-13
Toxicity+5
Treatment adherence+2

What helped?

No interventions yet.

LIFE OS recommendation

Monitoring Escalation ME-01

82%

probability of meaningful tolerance improvement

284 similar trajectories
100% showed improvement
median effect visible after 3 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

81 min

stable · -2.8 vs previous 14 d

Sleep duration

Wearable

6.2 h

worsening · -0.4 vs previous 14 d

Energy level

Daily log

4.7/10

worsening · -0.8 vs previous 14 d

Steps

Wearable

9,687

stable · -214 vs previous 14 d

GI burden

Companion

33.4/100

worsening · +10.4 vs previous 14 d

Adherence

Companion

92.8 %

stable · -2.0 vs previous 14 d

Sleep quality

Wearable

45.1/100

worsening · -8.6 vs previous 14 d

Glucose, CGM daily mean

CGM

132 mg/dL

stable · +1.2 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 62 from the failing basin, 26 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.
More protein
GI -9.7 next day on high-intake days · n 17

Would not help

Keep alcohol low
GI +7.5 next day on high-intake days · n 19

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-9.7supporter · 95%
Alcohol
+7.5detractor · 95%
Insoluble fibre
-1.5no signal · 23%
Simple carbohydrates
-1.4no signal · 18%
Ultra-processed food
+1.4no signal · 20%
Dietary fat load
-1no signal · 15%
Caffeine
-0.9no signal · 15%
Histamine load
+0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Autonomic recovery ↓45
- WearableResting HR 77 bpm
- WearableShort sleep window

DNA

Fictional pharmacogenomic panel

CYP2D6 Intermediate metabolizer
Expected exposure

Microbiome

Shannon diversity 4.4 · butyrate capacity 70/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisNormal
Bifidobacterium longumNormal
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 64 ms
Sleep: 6.6 h
Steps: 9,630
Resting HR: 72 bpm

Daily log: GI score 33, nutritional resilience 60, adherence 93.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02620	41%	S01	HY-01	improved	64
P-02462	40%	S12	DT-01	improved	65
P-02697	39%	S07	GI-04	improved	56
P-02082	38%	S12	NP-02	improved	53
P-02147	38%	S13	GI-04	improved	58
P-02235	37%	S14	DT-01	improved	50
P-02518	37%	S17	DT-01	improved	68
P-02645	37%	S02	HY-01	improved	56
P-02218	36%	S01	DT-01	improved	61
P-02274	36%	S15	DT-01	improved	50
P-02303	36%	S15	GI-04	improved	48
P-02479	36%	S13	DT-01	improved	48